who should not use a glp 1 GLP-1 Meds: What They Really Do and What They Don't The GLP-1 Diet: What to
Description
[DOI] [PubMed] [Google Scholar] 7.Yin J., Xing H., Ye J
Zepbound revenue soared from $175.8 million to $1.9 billion, while Mounjaro sales jumped 60% to $3.5 billion
While current data are encouraging, especially regarding cardiovascular benefits and renal protection, continuous research will help elucidate the full spectrum of effects and potential risks over the long term
Safety and efficiency of dipeptidyl peptidase IV inhibitors in patients with diabetic kidney disease: A systematic review and meta-analysis
Semaglutide mimics the effects of the hormone glucagon-like peptide-1 (GLP-1)
